| BANKAR, Aniket, Kristen PETTIT, Joseph SHATZEL, Abdulraheem YACOUB, Naveen PEMMARAJU, Harinder GILL, Antonin HLUSI, Alessandro LUCCHESI, Samah ALIMAM, Jiří MAYER, Francesca PALANDRI, Daniel SASCA, Katharina MODELSKA, Suneel K GUPTA, Ifode AJARI, Sarita KHANNA, Arturo MOLINA and Andrew Tucker KUYKENDALL. VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV). In 2024 ASCO Annual Meeting. 2024. ISSN 0732-183X. Available from: https://dx.doi.org/10.1200/JCO.2024.42.16_suppl.TPS6592. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{2424060,
author = {Bankar, Aniket and Pettit, Kristen and Shatzel, Joseph and Yacoub, Abdulraheem and Pemmaraju, Naveen and Gill, Harinder and Hlusi, Antonin and Lucchesi, Alessandro and Alimam, Samah and Mayer, Jiří and Palandri, Francesca and Sasca, Daniel and Modelska, Katharina and Gupta, Suneel K and Ajari, Ifode and Khanna, Sarita and Molina, Arturo and Kuykendall, Andrew Tucker},
booktitle = {2024 ASCO Annual Meeting},
doi = {http://dx.doi.org/10.1200/JCO.2024.42.16_suppl.TPS6592},
language = {eng},
title = {VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV).},
url = {https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.TPS6592},
year = {2024}
}
TY - CONF
ID - 2424060
AU - Bankar, Aniket - Pettit, Kristen - Shatzel, Joseph - Yacoub, Abdulraheem - Pemmaraju, Naveen - Gill, Harinder - Hlusi, Antonin - Lucchesi, Alessandro - Alimam, Samah - Mayer, Jiří - Palandri, Francesca - Sasca, Daniel - Modelska, Katharina - Gupta, Suneel K - Ajari, Ifode - Khanna, Sarita - Molina, Arturo - Kuykendall, Andrew Tucker
PY - 2024
TI - VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV).
UR - https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.TPS6592
ER -
BANKAR, Aniket, Kristen PETTIT, Joseph SHATZEL, Abdulraheem YACOUB, Naveen PEMMARAJU, Harinder GILL, Antonin HLUSI, Alessandro LUCCHESI, Samah ALIMAM, Jiří MAYER, Francesca PALANDRI, Daniel SASCA, Katharina MODELSKA, Suneel K GUPTA, Ifode AJARI, Sarita KHANNA, Arturo MOLINA and Andrew Tucker KUYKENDALL. VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV). In \textit{2024 ASCO Annual Meeting}. 2024. ISSN~0732-183X. Available from: https://dx.doi.org/10.1200/JCO.2024.42.16\_{}suppl.TPS6592.
|
